Phase I factorial study of temozolomide plus memantine, mefloquine, and metformin as post-radiation adjuvant therapy for newly diagnosed glioblastoma.
Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Stefania Maraka, Morris D. Groves, Aaron Gerald Mammoser, Isaac Melguizo-Gavilanes, Charles A. Conrad, Ivo Tremont-Lukats, Monica Elena Loghin, Barbara Jane O'Brien, Vinay K. Puduvalli, Erik P. Sulman, Kenneth R. Hess, Kenneth D. Aldape, Mark R. Gilbert, John Frederick De Groot, W. K. Alfred Yung, Marta Penas-Prado
Institutions: The University of Texas MD Anderson Cancer Center, Texas Oncology, Louisiana State University Health Sciences Center New Orleans, Aurora Health Care, Houston Methodist, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, National Cancer Institute, Center for Cancer Research
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2891196738